Ferring Sues Actavis Over Generic Blood Loss Drug
By Jeannie O'Sullivan ( June 24, 2015, 4:23 PM EDT) -- Global pharmaceutical group Ferring BV has accused a subsidiary of New Jersey-based Actavis Inc. of unlawfully making and selling a generic form of its blood loss treatment drug Lysteda before Ferring's patent on the original formula expired....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.